| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 879.46B | 840.40B | 832.54B | 763.52B | 600.57B |
| Gross Profit | 195.54B | 167.83B | 180.48B | 171.82B | 135.43B |
| EBITDA | 87.28B | 63.78B | 90.02B | 40.92B | 62.28B |
| Net Income | 4.42B | -13.83B | 10.63B | -33.76B | 4.13B |
Balance Sheet | |||||
| Total Assets | 1.12T | 1.04T | 1.02T | 959.40B | 946.49B |
| Cash, Cash Equivalents and Short-Term Investments | 57.56B | 65.31B | 51.18B | 69.31B | 60.46B |
| Total Debt | 547.17B | 522.73B | 500.56B | 491.54B | 499.69B |
| Total Liabilities | 931.98B | 901.05B | 865.16B | 834.53B | 777.13B |
| Stockholders Equity | 151.22B | 108.06B | 124.28B | 97.04B | 145.29B |
Cash Flow | |||||
| Free Cash Flow | -1.82B | 0.00 | 3.87B | 9.39B | 10.58B |
| Operating Cash Flow | 40.03B | 0.00 | 58.77B | 48.51B | 45.06B |
| Investing Cash Flow | -38.97B | -42.44B | -43.51B | -34.65B | -22.79B |
| Financing Cash Flow | -14.66B | 8.51B | -48.08B | -7.89B | -20.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥10.89T | 27.69 | 8.97% | 1.38% | 9.20% | 90.68% | |
74 Outperform | ¥556.13B | 9.24 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥805.67B | 49.00 | 7.20% | 2.41% | 3.37% | -62.36% | |
68 Neutral | ¥5.30T | 11.55 | 6.98% | 2.98% | 5.28% | 12.66% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.75T | 10.14 | 8.34% | 2.03% | 4.53% | 65.12% | |
48 Neutral | ¥67.59B | 10.65 | -8.11% | ― | 4.65% | ― |